What the six lenses say about MEDANTA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How MEDANTA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +3.0pp | +1.1pp | +6.8pp | +26.8pp | +21.4pp | +9.1pp |
Nifty 500 Broad-market baseline | +2.6pp | +1.0pp | +6.2pp | +23.2pp | +16.4pp | +5.2pp |
Sector Own-sector index | — | — | +4.5pp | +11.6pp | +3.6pp | -9.3pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
MEDANTA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
MEDANTA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 |
| ↳ change QoQ | — | +11.1% | -1.4% | -1.3% | +10.7% | +6.6% | +2.0% | +3.4% |
| EBITDA (₹cr) | 208 | 247 | 254 | 225 | 247 | 231 | 217 | 244 |
| EBITDA margin | 24.2% | 25.8% | 26.9% | 24.2% | 24.0% | 21.0% | 19.4% | 21.1% |
| PAT (₹cr) | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 |
| ↳ change QoQ | — | +23.1% | +9.2% | -29.3% | +57.4% | -0.6% | -39.9% | +49.5% |
| Net margin | 12.3% | 13.7% | 15.1% | 10.8% | 15.4% | 14.4% | 8.5% | 12.3% |
| EPS (₹) | 3.96 | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding MEDANTA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Kotak Midcap Reg Gr | 1.73% | 67,611 | |
| Canara Robeco Large & Mid Cap Reg Gr | 0.97% | 25,251 | |
| UTI Flexi Cap Reg Gr | 1.97% | 22,882 | |
| Canara Robeco Small Cap Reg Gr | 1.51% | 13,967 | |
| Invesco India Mid Cap Gr | 4.39% | 12,397 | |
| UTI Mid Cap Reg Gr | 1.05% | 12,122 | |
| Invesco India Smallcap Reg Gr | 2.23% | 11,717 | |
| Invesco India large& mid cap Gr | 2.00% | 10,153 | |
| PGIM India Flexi Cap Reg Gr | 1.05% | 5,733 | |
| HSBC Flexi Cap Gr | 0.97% | 5,538 |
ETFs holding MEDANTA (4)
| ETF | Weight | Grade |
|---|---|---|
| Groww BSE Hospitals ETF | 4.59% | |
| Motilal Oswal BSE Select IPO ETF | 0.93% | |
| Mirae Asset Nifty 500 Healthcare ETF | 0.80% | |
| Motilal Oswal BSE Healthcare ETF | 0.67% |